Clinical Trials
2 trialsNCT01240590 2017-04-10
A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00423410 2009-09-10
A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer
EpiCept Corporation
Phase 1 Completed